Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button


Home > Press > IQ Micro Presents at NSTI Nanotechnology Conference

IQ Micro Inc. (OTCBB: IQMC), exclusive licensor of electro-osmotic membranes and micro-pumps for the rapidly emerging microfluidic technology sector, announced today that it will give two presentations at the 10th annual NSTI Nanotechnology Conference and Trade Show and at the TechConnect Summit in Santa Clara Convention Center, Santa Clara, CA, on May 20-24, 2007.

IQ Micro Presents at NSTI Nanotechnology Conference

WEST PALM BEACH, FL | Posted on May 22nd, 2007

On May 23rd, IQ Micro Senior Scientist Trond Heldal will present, "Embeddable Low-Voltage Micropump using Electroosmosis of the Second Kind" under the "Micro & Nano Fluidics: Transport & Dispersion" session. On May 24th, Mr. Heldal will also present "Microfluidic pump and actuators" during the TechConnect Summit.

IQ Micro President and CEO Johnny Christiansen said, "The NSTI conference is the premier meeting place for research and businesses within the micro- and nanotechnology sector, and we are pleased that IQ Micro's technology has been accepted for two presentations at this year's conference."

About The NSTI Nanotechnology Conference and Trade Show

Since 1998, the NSTI Nanotechnology Conference and Trade Show has grown in both scope and audience. Last year's event attracted 3,000 worldwide attendees. The NSTI nanotechnology conference and trade show now ranks as the largest international nanotechnology conference in the world, focusing not only on scientists and researchers, but also on investors, venture capitalists and business executives interested in the ways that nanotechnology can drive business in the 21st century.


About IQ Micro Inc.
IQ Micro Inc. ( ) is an international licensing company that commercializes proprietary technology developed for use in the microfluidics sector. Developed from the micro-chip industry, microfluidics involves circuits of tiny chambers, channels and pumps that direct the flow of liquids on a single micro-chip.

IQ Micro is actively pursuing global licensing opportunities for its patented electro-osmotic membrane technology and its "invisible pump," a microfluidic technology with a wide range of consumer, medical and industrial applications. With its proprietary technology and highly experienced management, IQ Micro expects to become a leading global, specialized supplier of low-voltage microfluidic technology.

The recent Osmotex/Lifecare merger is expected to result in an expanded licensing arrangement with IQ Micro, which will include the exclusive sales and marketing rights to Lifecare's implantable, osmotic sensor for use in diabetes monitoring.

This release contains various forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended, which represent the company's expectations or beliefs concerning future events of the company's financial performance. These forward-looking statements are further qualified by important factors that could cause actual results to differ materially from those in the forward-looking statements. The words "may," "could," "should," "believe," "anticipate," "estimate," "expect," "intend," "plan" and similar words are intended to identify forward-looking statements. These factors include the effect of competitive pricing, the company's dependence on the ability of third-party manufacturers to produce components on a basis which is cost-effective to the company, our ability to protect our intellectual property rights from infringement by third parties, our ability to convert our intellectual property rights into product offerings that are accepted by the market, the development of competitors of intellectual property and associated products that are superior to ours or that gain better market acceptance than ours and the ability of our intellectual property rights to keep pace with the advances in technology, market acceptance of the company's products and licensing rights, the effects of government regulation and other factors. Results actually achieved may differ materially from expected results included in these statements. The company is under no obligation to, and expressly disclaims any such obligation to, update or alter its forward-looking statements, whether as a result of new information, future events or otherwise. Furthermore, this company cautions that the risk factors listed in this paragraph are not exhaustive.

For more information, please click here

D.P. Martin & Associates
Investor Relations for IQ Micro

Copyright © Market Wire

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press


Stanford technology makes metal wires on solar cells nearly invisible to light November 27th, 2015

Dimensionality transition in a newly created material November 27th, 2015

Nanoparticles simplify DNA identification and quantification November 27th, 2015

A new form of real gold, almost as light as air November 27th, 2015

Patents/IP/Tech Transfer/Licensing

Electric fields remove nanoparticles from blood with ease November 24th, 2015

Calling All Industries: Get Your Graphene By The Kiloton November 21st, 2015

Nanotech-based sensor developed to measure microRNAs in blood, speed cancer detection November 19th, 2015

Arrowhead Late-Breaking Clinical Data Shows that ARC-520 Can Produce Deep and Durable Reductions of Hepatitis B Viral Antigens and DNA November 16th, 2015


Stanford technology makes metal wires on solar cells nearly invisible to light November 27th, 2015

Nanometrics Announces Upcoming Investor Events November 18th, 2015

FEI and ICON Analytical Demonstrate the Power of TEM for Materials and Life Sciences Research: FEIís Talos scanning transmission electron microscope will be available for demos and workshops at the Indian Institute of Science from 23 November to 15 December 2015 November 17th, 2015

Arrowhead Presents Data Showing Robust Sustained Anti-viral Effects with ARC-520 in Hepatitis B Infected Chimpanzees November 15th, 2015

The latest news from around the world, FREE

  Premium Products
Only the news you want to read!
 Learn More
University Technology Transfer & Patents
 Learn More
Full-service, expert consulting
 Learn More

Nanotechnology Now Featured Books


The Hunger Project

Car Brands
Buy website traffic